{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T16:59:08Z","timestamp":1790009948716,"version":"4.0.1"},"publisher-location":"Cham","reference-count":35,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319571911","type":"print"},{"value":"9783319571935","type":"electronic"}],"license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017]]},"DOI":"10.1007\/978-3-319-57193-5_14","type":"book-chapter","created":{"date-parts":[[2017,7,3]],"date-time":"2017-07-03T05:03:24Z","timestamp":1499058204000},"page":"365-382","source":"Crossref","is-referenced-by-count":13,"title":["Leukodystrophy: Basic and Clinical"],"prefix":"10.1007","author":[{"given":"Gerald V.","family":"Raymond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,4]]},"reference":[{"issue":"3","key":"14_CR1","first-page":"140","volume":"3","author":"HW Moser","year":"2007","unstructured":"Moser HW, Mahmood A, Raymond GV (2007) X-linked adrenoleukodystrophy. Nature clinical practice. Neurology 3(3):140\u2013151","journal-title":"Neurology"},{"issue":"3","key":"14_CR2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1212\/01.WNL.0000079050.91337.83","volume":"61","author":"DJ Loes","year":"2003","unstructured":"Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW et al (2003) Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61(3):369\u2013374","journal-title":"Neurology"},{"issue":"6414","key":"14_CR3","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/361726a0","volume":"361","author":"J Mosser","year":"1993","unstructured":"Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H et al (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with Abc transporters. Nature 361(6414):726\u2013730","journal-title":"Nature"},{"issue":"6","key":"14_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/humu.1227","volume":"18","author":"S Kemp","year":"2001","unstructured":"Kemp S, Pujol A, Waterham HR, van Geel BM, Boehm CD, Raymond GV et al (2001) ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat 18(6):499\u2013515","journal-title":"Hum Mutat"},{"issue":"9","key":"14_CR5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.bbadis.2012.03.012","volume":"1822","author":"S Kemp","year":"2012","unstructured":"Kemp S, Berger J, Aubourg P (2012) X-linked adrenoleukodystrophy: clinical, metabolic, genetic and pathophysiological aspects. Biochim Biophys Acta 1822(9):1465\u20131474","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"14_CR6","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/j.1476-5381.2011.01435.x","volume":"164","author":"S Kemp","year":"2011","unstructured":"Kemp S, Theodoulou FL, Wanders RJ (2011) Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance. Br J Pharmacol 164(7):1753\u20131766","journal-title":"Br J Pharmacol"},{"key":"14_CR7","first-page":"S80","volume":"59","author":"A Pujol","year":"2011","unstructured":"Pujol A, Fourcade S, Galino J, Morato L, Erauskin JL, Ruiz M et al (2011) Oxidative stress, mitochondria depletion and oxidation in the peroxisomal disease adrenoleukodystrophy. Glia 59:S80","journal-title":"Glia"},{"issue":"8","key":"14_CR8","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1089\/ars.2010.3877","volume":"15","author":"J Galino","year":"2011","unstructured":"Galino J, Ruiz M, Fourcade S, Schluter A, Lopez-Erauskin J, Guilera C et al (2011) Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy. Antioxid Redox Signal 15(8):2095\u20132107","journal-title":"Antioxid Redox Signal"},{"issue":"9","key":"14_CR9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1016\/j.bbadis.2012.02.005","volume":"1822","author":"E Galea","year":"2012","unstructured":"Galea E, Launay N, Portero-Otin M, Ruiz M, Pamplona R, Aubourg P et al (2012) Oxidative stress underlying axonal degeneration in adrenoleukodystrophy: a paradigm for multifactorial neurodegenerative diseases? Biochim Biophys Acta 1822(9):1475\u20131488","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"14_CR10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/ana.22363","volume":"70","author":"J Lopez-Erauskin","year":"2011","unstructured":"Lopez-Erauskin J, Fourcade S, Galino J, Ruiz M, Schluter A, Naudi A et al (2011) Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy. Ann Neurol 70(1):84\u201392","journal-title":"Ann Neurol"},{"key":"14_CR11","doi-asserted-by":"crossref","unstructured":"Berger J, Forss-Petter S, Eichler FS (2014) Pathophysiology of X-linked adrenoleukodystrophy. Biochimie 98:135\u2013142. doi:10.1016\/j.biochi.2013.11.023. Epub@2013 Dec 4.:135-42.","DOI":"10.1016\/j.biochi.2013.11.023"},{"issue":"10","key":"14_CR12","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/jnen\/60.10.1004","volume":"60","author":"M Ito","year":"2001","unstructured":"Ito M, Blumberg BM, Mock DJ, Goodman AD, Moser AB, Moser HW et al (2001) Potential environmental and host participants in the early white matter lesion of adreno-leukodystrophy: morphologic evidence for CD8 cytotoxic T cells, cytolysis of oligodendrocytes, and CD1-mediated lipid antigen presentation. J Neuropathol Exp Neurol 60(10):1004\u20131019","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"14_CR13","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1182\/blood-2003-10-3402","volume":"104","author":"C Peters","year":"2004","unstructured":"Peters C, Charnas LR, Tan Y, Ziegler RS, Shapiro EG, Defor T et al (2004) Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 104(3):881\u2013888","journal-title":"Blood"},{"issue":"8","key":"14_CR14","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S1474-4422(07)70177-1","volume":"6","author":"A Mahmood","year":"2007","unstructured":"Mahmood A, Raymond GV, Raymond P, Dubey P, Peters C, Moser HW (2007) Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol 6(8):687\u2013692","journal-title":"Lancet Neurol"},{"issue":"10","key":"14_CR15","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1089\/hum.2007.1031","volume":"18","author":"N Cartier","year":"2007","unstructured":"Cartier N, Hacein-Bey-Abina S, Veres G, Vidaud M, Dal Cortivo L, Caccavelli L et al (2007) Preliminary data from the first hematopoietic stem cell gene therapy trial with lentiviral vector demonstrate expression of the therapeutic protein in high percentage of lymphocytes and monocytes in two patients with X-linked adrenoleukodystrophy. Hum Gene Ther 18(10):941","journal-title":"Hum Gene Ther"},{"issue":"5954","key":"14_CR16","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I et al (2009) Hematopoietic stem cell Gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326(5954):818\u2013823","journal-title":"Science"},{"issue":"1","key":"14_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12031-007-0041-4","volume":"33","author":"HW Moser","year":"2007","unstructured":"Moser HW, Moser AB, Hollandsworth K, Brereton NH, Raymond GV (2007) \u201cLorenzo\u2019s oil\u201d therapy for X-linked adrenoleukodystrophy: rationale and current assessment of efficacy. J Mol Neurosci 33(1):105\u2013113","journal-title":"J Mol Neurosci"},{"issue":"7","key":"14_CR18","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archneur.62.7.1073","volume":"62","author":"HW Moser","year":"2005","unstructured":"Moser HW, Raymond GV, SE L, Muenz LR, Moser AB, JH X et al (2005) Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo\u2019s oil. Arch Neurol 62(7):1073\u20131080","journal-title":"Arch Neurol"},{"issue":"1","key":"14_CR19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.gene.2014.09.046","volume":"555","author":"AC Graziano","year":"2015","unstructured":"Graziano AC, Cardile V (2015) History, genetic, and recent advances on Krabbe disease. Gene 555(1):2\u201313","journal-title":"Gene"},{"issue":"9","key":"14_CR20","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/08830738030180090201","volume":"18","author":"K Suzuki","year":"2003","unstructured":"Suzuki K (2003) Globoid cell leukodystrophy (Krabbe\u2019s disease): update. J Child Neurol 18(9):595\u2013603","journal-title":"J Child Neurol"},{"issue":"4","key":"14_CR21","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1098-1004(1997)10:4<268::AID-HUMU2>3.0.CO;2-D","volume":"10","author":"DA Wenger","year":"1997","unstructured":"Wenger DA, Rafi MA, Luzi P (1997) Molecular genetics of Krabbe disease (globoid cell leukodystrophy): diagnostic and clinical implications. Hum Mutat 10(4):268\u2013279","journal-title":"Hum Mutat"},{"issue":"3","key":"14_CR22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1022436928925","volume":"23","author":"K Suzuki","year":"1998","unstructured":"Suzuki K (1998) Twenty five years of the \u201cpsychosine hypothesis\u201d: a personal perspective of its history and present status. Neurochem Res 23(3):251\u2013259","journal-title":"Neurochem Res"},{"issue":"2","key":"14_CR23","first-page":"136","volume":"9","author":"T Miyatake","year":"1973","unstructured":"Miyatake T, Suzuki K (1973) Additional deficiency of psychosine galactosidase in globoid cell leukodystrophy: an implication to enzyme replacement therapy. Birth Defects Orig Artic Ser 9(2):136\u2013140","journal-title":"Birth Defects Orig Artic Ser"},{"issue":"3","key":"14_CR24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0006-291X(72)90381-6","volume":"48","author":"T Miyatake","year":"1972","unstructured":"Miyatake T, Suzuki K (1972) Globoid cell leukodystrophy: additional deficiency of psychosine galactosidase. Biochem Biophys Res Commun 48(3):539\u2013543","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"14_CR25","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3174\/ajnr.A1476","volume":"30","author":"ML Escolar","year":"2009","unstructured":"Escolar ML, Poe MD, Smith JK, Gilmore JH, Kurtzberg J, Lin W et al (2009) Diffusion tensor imaging detects abnormalities in the corticospinal tracts of neonates with infantile Krabbe disease. AJNR Am J Neuroradiol 30(5):1017\u20131021","journal-title":"AJNR Am J Neuroradiol"},{"issue":"1","key":"14_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2214\/AJR.07.3885","volume":"192","author":"JM Provenzale","year":"2009","unstructured":"Provenzale JM, Peddi S, Kurtzberg J, Poe MD, Mukundan S, Escolar M (2009) Correlation of neurodevelopmental features and MRI findings in infantile Krabbe\u2019s disease. AJR Am J Roentgenol 192(1):59\u201365","journal-title":"AJR Am J Roentgenol"},{"issue":"20","key":"14_CR27","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1056\/NEJMoa042604","volume":"352","author":"ML Escolar","year":"2005","unstructured":"Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S et al (2005) Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease. N Engl J Med 352(20):2069\u20132081","journal-title":"N Engl J Med"},{"issue":"1","key":"14_CR28","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.seminhematol.2009.10.006","volume":"47","author":"PJ Orchard","year":"2010","unstructured":"Orchard PJ, Tolar J (2010) Transplant outcomes in leukodystrophies. Semin Hematol 47(1):70\u201378","journal-title":"Semin Hematol"},{"issue":"5","key":"14_CR29","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.pediatrneurol.2014.08.003","volume":"51","author":"Y Li","year":"2014","unstructured":"Li Y, Sands MS (2014) Experimental therapies in the murine model of globoid cell leukodystrophy. Pediatr Neurol 51(5):600\u2013606","journal-title":"Pediatr Neurol"},{"issue":"16","key":"14_CR30","doi-asserted-by":"crossref","first-page":"6495","DOI":"10.1523\/JNEUROSCI.4199-14.2015","volume":"35","author":"JA Hawkins-Salsbury","year":"2015","unstructured":"Hawkins-Salsbury JA, Shea L, Jiang X, Hunter DA, Guzman AM, Reddy AS et al (2015) Mechanism-based combination treatment dramatically increases therapeutic efficacy in murine globoid cell leukodystrophy. J Neurosci 35(16):6495\u20136505","journal-title":"J Neurosci"},{"issue":"15","key":"14_CR31","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1523\/JNEUROSCI.5384-11.2012","volume":"32","author":"A Messing","year":"2012","unstructured":"Messing A, Brenner M, Feany MB, Nedergaard M, Goldman JE (2012) Alexander disease. J Neurosci 32(15):5017\u20135023","journal-title":"J Neurosci"},{"issue":"3","key":"14_CR32","first-page":"541","volume":"22","author":"MS Knaap van der","year":"2001","unstructured":"van der Knaap MS, Naidu S, Breiter SN, Blaser S, Stroink H, Springer S et al (2001) Alexander disease: diagnosis with MR imaging. AJNR Am J Neuroradiol 22(3):541\u2013552","journal-title":"AJNR Am J Neuroradiol"},{"issue":"5","key":"14_CR33","first-page":"e00125","volume":"5","author":"MH Chen","year":"2013","unstructured":"Chen MH, Hagemann TL, Quinlan RA, Messing A, Perng MD (2013) Caspase cleavage of GFAP produces an assembly-compromised proteolytic fragment that promotes filament aggregation. ASN Neuro 5(5):e00125","journal-title":"ASN Neuro"},{"issue":"9","key":"14_CR34","doi-asserted-by":"crossref","first-page":"e0138132","DOI":"10.1371\/journal.pone.0138132","volume":"10","author":"CM LaPash Daniels","year":"2015","unstructured":"LaPash Daniels CM, Paffenroth E, Austin EV, Glebov K, Lewis D, Walter J et\u00a0al (2015) Lithium decreases glial fibrillary acidic protein in a mouse model of Alexander disease. PLoS One 10(9):e0138132","journal-title":"PLoS One"},{"issue":"15","key":"14_CR35","first-page":"10","volume":"114","author":"BH Vogel","year":"2015","unstructured":"Vogel BH, Bradley SE, Adams DJ, D'Aco K, Erbe RW, Fong C et al (2015) Newborn screening for X-linked adrenoleukodystrophy in New York state: diagnostic protocol, surveillance protocol and treatment guidelines. Mol Genet Metab 114(15):10","journal-title":"Mol Genet Metab"}],"container-title":["Advances in Neurobiology","Neurodegenerative Diseases"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-57193-5_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T16:16:36Z","timestamp":1505319396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-57193-5_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"ISBN":["9783319571911","9783319571935"],"references-count":35,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-57193-5_14","relation":{},"ISSN":["2190-5215","2190-5223"],"issn-type":[{"value":"2190-5215","type":"print"},{"value":"2190-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}